Myricx Pharma (private company)

myricxpharma.com Follow

See something wrong or missing? Let us know

Offices:

London

Category:

Health services Pharma

Business model:

B2B

Investors:

we tracked 2 investors

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer

Companies with similar profile to Myricx Pharma:

Company	Criteria
AFYX Therapeutics 56%	Similar verticals: Health services, Pharma Similar business models: B2B At least one vc investor: Sofinnova Partners Minim one investor from outside Scandinavia: Yes
EnginZyme 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Sofinnova Partners Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Oncomatryx 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Synapse Medicine 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Aignostics 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Semalytix 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Amadix 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Ability Pharma 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
AbolerIS Pharma 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Sanifit Therapeutics 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Curida 44%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 5M - 10M USD
Biosyntia 44%	Similar business models: B2B At least one vc investor: Sofinnova Partners Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
OnDosis 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Bigfinite 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
NMD Pharma 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
T3 Pharmaceuticals 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Citryll 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Asarina Pharma 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Pharvaris 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Owkin 44%	Similar verticals: Health services, Pharma Similar business models: B2B Minim one investor from outside Scandinavia: Yes